1Targeted regulation of microRNA?150?3p on IGF1 expression and its effect on invasion and migration of gastric cancer cellsYANG Chaowen, DING Chengming, GUI Pucheng, YU ZijianARTICLES769-7732Experimental study on inhibition of migration and invasion of lung cancer cells by miR?144?3p targeting ONECUT2LU Zhansheng, LIU Bo, SUN Yongpan, KONG Demiao, YAO Jing, ZHOU Xiaojiang, XU Chuan, LUO Meng, ZHANG QingbinARTICLES774-7783Reversal of tamoxifen resistance in breast cancer cells by silencing GPER1 expressionLI Xiaotian, XUE Guojun, YANG GuanglunARTICLES779-7844The effect of miR?29c?5p on the proliferation and migration of clear cell renal carcinoma cells by negatively regulating CPEB4XU Zhihua, WANG Dong, Wang JinARTICLES785-7905Experimental study on the effects of miR?671?3p on proliferation and apoptosis of glioma cellsLEI Yi, DENG Teng, CHEN Hainan, HUANG Qianrong, MO LigenARTICLES791-7946Effects of methylation of RASSF10 promoter on proliferation and apoptosis of lung cancer cellsBI Jing, YU Rui, HUANG Bo, XIE ZhaofengARTICLES795-7997Case?control study on LSP1 rs3817198 locus and susceptibility to breast cancerLI Rui, HAN Tongliang, SUN Bei, XIA Liangxu, QI Yaoyue, QIU Wensheng, WEI HongmeiARTICLES800-8038Expression and clinical significance of MALAT1 and fibroblast growth factor 2 in thyroid micropapillary carcinomaHAN Zhirong, FENG Zejin, HAN Liang, HU YuezhenARTICLES804-8079Expression and clinical significance of PD?1／PD?L1 and CD8+Tils in cervical squamous cell carcinomaSONG Chen, LIANG Gang, SHI Jiangbo, ZHENG HuixiaARTICLES808-81310Effect of anemia on prognosis of patients with synchronous colorectal liver metastasesPAN Jun, QIN Shukui, CHEN Yingxia, HUANG Yong, QU Wengshu, MEI Kuimin, ZHU ChunyanARTICLES814-81811Clinical observation of postoperative precise radiotherapy for 270 patients with gliomaHUANG Renhua, XU Xin, WU Zheng, ZHOU Di, XIE Huaying, YE Ming, MA Xiumei, BAI YongruiARTICLES819-82312The clinical observation of modified ShumuLiujunzi Decoction for type 1 gastric neuroendocrine neoplasmDOU Dou, QIU Xudong, CHEN Yingying, LI Yuanliang, QI Zhirong, LIU Jixi, LUO Jie, TAN HuangyingCLINICAL PRACTICE824-82713Current status and progression of molecular targeted drugs and immunological checkpoint inhibitors in the treatment of advanced hepatocellular carcinomaLIU Lin, QIN ShuiquiREVIEW AND LECTURES839-84914Progression of recombinant human endostatin in the treatment of malignant pleural effusionMIAO Jing, QIN ShukuiREVIEW AND LECTURES850-85515Progression of recombinant human endostatin ( endostar) intraperitoneal injection for the treatment of ma?lignant ascitesCHAO Jiaojiao, QIN ShuquiREVIEW AND LECTURES856-861 